A real-world comparison among third-generation antiseizure medications: results from the COMPARE study.

Roberta RobertiGianfranco Di GennaroFrancesca AnzellottiDario ArnaldiVincenzo BelcastroSimone BerettaGiovanni BoeroPaolo BonanniCanafoglia LauraAlfredo D'AnielloFilippo DaineseCarmen De CaroGiancarlo Di GennaroRoberta di Giacomo DiFrancesco Jacopo Cosimo Fedele Dono Giovanni FalcicchioEdoardo FerlazzoNicoletta FoschiSilvia FranciottaAntonio GambardellaAlfonso GiordanoLuigi Francesco IannoneAngelo LabateAngela La NeveSimona LattanziUgo LeggioClaudio LiguoriMarta MaschioAnnacarmen Nilo Francesca Felicia Operto Angelo PascarellaGiada PaulettoRosaria RennaGionata Strigaronull nullEmilio Russo

Published in: Epilepsia (2023)

Comparative evidence from real-world studies may help clinicians to tailor treatments according to patients' demographic and clinical characteristics.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
palliative care
peritoneal dialysis
patient reported outcomes
case control
clinical evaluation